{"id":727355,"date":"2023-01-31T16:12:09","date_gmt":"2023-01-31T21:12:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/"},"modified":"2023-01-31T16:12:09","modified_gmt":"2023-01-31T21:12:09","slug":"goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/","title":{"rendered":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call"},"content":{"rendered":"

<\/p>\n

\nGoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call\n<\/p>\n

SANTA MONICA, Calif.–(BUSINESS WIRE<\/a>)–GoodRx Holdings Inc.<\/a> (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company\u2019s business outlook.\n<\/p>\n

\nTo access the conference call, please pre-register using this link<\/a>. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company\u2019s investor relations website at https:\/\/investors.goodrx.com<\/a>, where accompanying materials will be posted prior to the conference call.\n<\/p>\n

\nApproximately one hour after completion of the live call, an archived version of the webcast will be available on the Company\u2019s investor relations website at https:\/\/investors.goodrx.com<\/a> for at least 30 days.\n<\/p>\n

About GoodRx<\/b><\/p>\n

\nGoodRx is a leading digital healthcare platform that makes healthcare affordable and convenient for all Americans. We offer consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. Since 2011, we have helped consumers save over $45 billion and are one of the most downloaded medical apps over the past decade.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230131005919\/en\/<\/a><\/span><\/p>\n

Investor Contact
\n<\/b>
GoodRx
\n
Whitney Notaro
\n
ir@goodrx.com<\/a><\/p>\n

Press Contact
\n<\/b>
GoodRx
\n
Lauren Casparis
\n
lcasparis@goodrx.com<\/a><\/p>\n

KEYWORDS:<\/b> California United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Telemedicine\/Virtual Medicine Insurance Pharmaceutical Internet Managed Care Health Professional Services Technology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company\u2019s business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company\u2019s investor relations website at … <\/p>\n

Continue reading “GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727355","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company\u2019s business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company\u2019s investor relations website at … Continue reading "GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T21:12:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call\",\"datePublished\":\"2023-01-31T21:12:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/\"},\"wordCount\":304,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/\",\"name\":\"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2023-01-31T21:12:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/","og_locale":"en_US","og_type":"article","og_title":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk","og_description":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx Holdings Inc. (Nasdaq: GDRX), a leading digital healthcare platform, today announced it will release its fourth quarter and full year 2022 financial results after U.S. markets close on Tuesday, February 28, 2023. GoodRx management will also hold a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss the results and the Company\u2019s business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company\u2019s investor relations website at … Continue reading \"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T21:12:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call","datePublished":"2023-01-31T21:12:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/"},"wordCount":304,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/","name":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en","datePublished":"2023-01-31T21:12:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20230131005919r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/goodrx-announces-date-for-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GoodRx Announces Date for Fourth Quarter and Full Year 2022 Earnings Release and Conference Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727355"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727355\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}